Factors associated with the presence of high blood pressure in people younger than 45 years old
https://doi.org/10.52727/2078-256X-2025-21-2-156-165
Abstract
The aim of the study was to identify factors associated with the presence of high blood pressure (BP) in people under 45 years of age. Material and methods. The study included residents of Novosibirsk 25–44 years old, examined in 2013–2017 in Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics – 211 persons (46 % men, 54 % women). The examination program included: demographic and social data, survey about smoking and alcohol consumption habits, socioeconomic survey, history of chronic diseases, cardiological survey according to Rose, anthropometry (height, weight, waist circumference, calculation of body mass index, assessment of abdominal obesity), 3 times blood pressure measurement. Blood lipid profile and glucose were measured by enzymatic method using standard Thermo Fisher Scientific reagents on an automatic biochemical analyzer KoneLab 30i (Thermo Fisher Scientific, Finland). Results. According to the results of multivariate logistic regression analysis, the presence of elevated BP in individuals under 45 years of age was associated with glucose levels (odds ratio – OR = 1, 882, 95 % confidence interval – 95 % CI 1.021–3.469, p = 0.043), low-density lipoprotein cholesterol (OR = 1.902, 95 % CI 1.096–3.301, p = 0.022), total cholesterol (OR = 1.919, 95 % CI 1.067–3.452, p = 0.030) and triglycerides (OR = 1.913, 95 % CI 1.010–3.626, p = 0.047) in blood. Conclusions. In young people under 45 years of age, the presence of elevated BP is directly associated with disorders of lipid and carbohydrate metabolism.
Keywords
About the Authors
S. R. LedovskikhRussian Federation
Sofiya R. Ledovskikh, PhD student, researcher at the laboratory of genetic and environmental determinants of the human life cycle
175/1, Boris Bogatkov st., Novosibirsk, 630089
L. V. Shcherbakova
Russian Federation
Lilia V. Shcherbakova, senior researcher at the laboratory of clinical-population and preventive research of therapeutic and endocrine diseases
175/1, Boris Bogatkov st., Novosibirsk, 630089
D. V. Denisova
Russian Federation
Diana V. Denisova, doctor of medical sciences, chief researcher, laboratory of preventive medicine
175/1, Boris Bogatkov st., Novosibirsk, 630089
V. S. Shramko
Russian Federation
Victoria S. Shramko, candidate of medical sciences, researcher at the laboratory of clinical biochemical and hormonal studies of therapeutic diseases
175/1, Boris Bogatkov st., Novosibirsk, 630089
O. V. Pushkina
Russian Federation
Olga V. Pushkina, doctor of clinical laboratory diagnostics, employee of the laboratory of clinical, biochemical, hormonal studies of therapeutic diseases
175/1, Boris Bogatkov st., Novosibirsk, 630089
Yu. I. Ragino
Russian Federation
Yulia I. Ragino, doctor of medical sciences, Professor, corresponding member of the RAS, chief researcher of the laboratory of clinical biochemical and hormonal studies of therapeutic diseases, head of IIPM – Branch of ICiG SB RAS
175/1, Boris Bogatkov st., Novosibirsk, 630089
References
1. Barbarash O.L., Karpov Yu.A., Panov A.V., Akchurin R.S., Alekyan B.G., Alekhin M.N., Aronov D.M., Аrutyunyan G.K., Belenkov Yu.N., Boytsov S.A., Boldueva S.A., Boshchenko A.A., Bubnova M.G., Bulkina O.S., Vasyuk Yu.A., Galyavich A.S., Glezer M.G., Golubev E.P., Golukhova E.Z., Grinshtein Yu.I., Davidovich I.M., Yezhov M.V., Zavadovsky K.V., Irtyuga O.B., Karpov R.S., Kashtalap V.V., Koziolova N.A., Korennova O.Yu., Kosmacheva E.D., Koshelskaya O.A., Kukharchuk V.V., Lopatin Yu.M., Merkulov E.V., Mironov V.M., Martsevich S.Yu., Mirolyubova O.A., Mikhin V.P., Nedoshivin A.O., Nikulina N.N., Nikulina S.Yu., Oleinikov V.E., Panchenko E.P., Perepech N.B., Petrova M.M., Protasov K.V., Saidova M.A., Samko A.N., Sergienko I.V., Sinitsyn V.E., Skibitsky V.V., Soboleva G.N., Shalaev S.V., Shaposhnik I.I., Shevchenko A.O., Shiryaev A.A., Shlyakhto E.V., Chumakova G.A., Yakushin S.S. Сlinical practice guidelines for stable coronary artery disease. Russian Journal of Cardiology, 2024; 29 (9): 166–229. (In Russ.)]. doi: 10.15829/1560-4071-2024-6110
2. Lloyd-Jones D.M., Evans J.C., Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA, 2005; 294 (4): 466–472. doi: 10.1001/jama.294.4.466
3. Boytsov S.A., Pogosova N.V., Ansheles A.A., Badtieva V.A., Balakhonova T.V., Barbarash O.L., Vasyuk Yu.A., Gambaryan M.G., Gendlin G.E., Golitsyn S.P., Drapkina O.M., Drozdova L.Yu., Yezhov M.V., Ershova A.I., Zhirov I.V., Karpov Yu.A., Kobalava Zh.D., Kontsevaya A.V., Litvin A.Yu., Lukyanov M.M., Martsevich S.Yu., Matskeplishvili S.T., Metelskaya V.A., Meshkov A.N., Mishina I.E., Panchenko E.P., Popova A.B., Sergienko I.V., Smirnova M.D., Smirnova M.I., Sokolova O.Yu., Starodubova A.V., Sukhareva O.Yu., Ternovoy S.K., Tkacheva O.N., Shalnova S.A., Shestakova M.V. Сardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology, 28 (5): 119–249. (In Russ.)]. doi: 10.15829/1560-4071-2023-5452
4. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. Jr.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120 (16): 1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644
5. Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 2019; 290: 140–205. doi: 10.1016/j.atherosclerosis.2019.08.014
6. Karamnova N.S., Rytova A.I., Shvabskaya O.B., Makarova Yu.K., Maksimov S.A., Balanova Yu.А., Evstifeeva S.E., Imaeva A.E., Kapustina A.V., Muromtseva G.A., Shalnova S.A., Drapkina O.M. Associations of eating and drinking habits with cardiovascular disease and diabetes in the adult population: data from the ESSE-RF epidemiological study. Cardiovascular Therapeutics and Prevention, 2021; 20 (5): 233–242. (In Russ.)]. doi: 10.15829/1728-8800-2021-2982
7. Lyamina N.P., Nalivaeva A.V., Senchikhin V.N., Lipchanskaya T.P. Expression of cardiovascular and behavioral risk factors in masked and stable arterial hypertension among the young age group. Arterial Hypertension, 2016; 22 (3): 244–252 (In Russ.)].
8. Bagdulina E.N., Tsyganova O.V., Fedorova E.L., Bondareva Z.G. Risk factors of arterial hypertensia progress at young women (till 40 years). Medicine and Education in Siberia, 2013; 4: 69. (In Russ.)].
9. Antropova O.N., Silkina S.B., Osipova I.V., Smyshlyaeva T.L., Batanina I.A. Cardiovascular risk factors in young individuals with high normal blood pressure and essential arterial hypertension. Siberian Medical Journal (Tomsk), 2019; 34 (4): 101–111 (In Russ).]. doi: 10.29001/2073-8552-2019-34-4-101-111
10. Nutchin A.K., Mikhaylova A.O. Lipid profile in patients with arterial hypertension across different age-gender categories undergoing diagnosis and treatment in a day hospital. Scientific Community of the XXI Century: Problems and Solutions: proc. conf. Anapa, 2023. P. 28–35. (In Russ.)].
11. Li X., Wang J., Shen X., An Y., Gong Q., Li H., Zhang B., Shuai Y., Chen Y., Hu Y., Li G. Higher blood pressure predicts diabetes and enhances longterm risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study. J. Diabetes, 2019; 11 (7): 593–598. doi: 10.1111/17530407.12887.
12. Moiseev V.S., Mukhin N.A., Smirnov A.V., Kobalava Zh.D., Bobkova I.N., Villevalde S.V., Efremovtseva M.A., Kozlovskaya L.V., Shvetsov M.Yu., Shestakova M.V., Grinshtein Yu.I., Arutyunov G.P., Boitsov S.A., Galyavich A.S., Dobronravov V.A., Drapkina O.M., Ermolenko V.M., Karpov Yu.A., Kayukov I.G., Kotovskaya Yu.V., Kukharchuk V.V., Martynov A.I., Moiseev S.V., Morozova T.E., Oganov R.G., Podzolkov V.I., Rozhinskaya L.Ya., Tereshchenko S.N., Fomin V.V., Khirmanov V.N., Chazova I.E., Shamkhalova M.Sh., Shilov E.M., Shlyakhto E.V., Shutov A.M. Cardiovascular risk and chronic kidney disease: strategy for cardio-nephroprotection. Russian Journal of Cardiology, 2014; 112 (8): 7–37. (In Russ.)]. doi: 10.15829/1560-4071-2014-8-7-37
Review
For citations:
Ledovskikh S.R., Shcherbakova L.V., Denisova D.V., Shramko V.S., Pushkina O.V., Ragino Yu.I. Factors associated with the presence of high blood pressure in people younger than 45 years old. Ateroscleroz. 2025;21(2):156-165. (In Russ.) https://doi.org/10.52727/2078-256X-2025-21-2-156-165